ADC start­up Du­al­i­ty­Bio seeks Hong Kong IPO amid pre­car­i­ous mar­ket

Mul­ti-part­nered ADC start­up Du­al­i­ty Bi­o­log­ics is mov­ing for­ward with its ini­tial pub­lic of­fer­ing plans on the Hong Kong Stock Ex­change (HKEX).

Du­al­i­ty­Bio ex­pects to get …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA